<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Endang Sukandar on Medium]]></title>
        <description><![CDATA[Stories by Endang Sukandar on Medium]]></description>
        <link>https://medium.com/@esukandar1608?source=rss-3b72b6ef4763------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*yWCAnHTPr4sZ1Q9e5THsUg.png</url>
            <title>Stories by Endang Sukandar on Medium</title>
            <link>https://medium.com/@esukandar1608?source=rss-3b72b6ef4763------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Fri, 20 Nov 2026 05:07:39 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@esukandar1608/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Power, Leverage, and Outcome: When Power Does Not Always Determine the Result]]></title>
            <link>https://medium.com/@esukandar1608/power-leverage-and-outcome-when-power-does-not-always-determine-the-result-59ffb0f552fe?source=rss-3b72b6ef4763------2</link>
            <guid isPermaLink="false">https://medium.com/p/59ffb0f552fe</guid>
            <category><![CDATA[outcomes]]></category>
            <category><![CDATA[business-strategy]]></category>
            <category><![CDATA[management]]></category>
            <category><![CDATA[negotiation]]></category>
            <category><![CDATA[leverage]]></category>
            <dc:creator><![CDATA[Endang Sukandar]]></dc:creator>
            <pubDate>Mon, 02 Nov 2026 03:40:42 GMT</pubDate>
            <atom:updated>2026-11-14T16:17:44.770Z</atom:updated>
            <content:encoded><![CDATA[<p>Endang Sukandar | 2026</p><p>One of the activities I enjoy after work is watching films. For me, it is a simple way to unwind after a busy day. However, there was one particular conversation in the film Animals (2026) that made me reflect on how power actually works, especially in leadership, management, negotiation, and business decision-making.</p><p><strong>&quot;Power creates leverage, and leverage dictates outcomes.&quot;</strong></p><p>This statement, delivered by Dayle Burton, a negotiator in the film, sounds relatively simple. Yet, upon closer reflection, it offers an interesting perspective on how power can influence someone&#39;s bargaining position and ultimately shape the direction of a decision.</p><p>In professional life, we often assume that individuals who hold higher positions or control more resources automatically possess greater power. In reality, however, this is not always the case.</p><p>A leader may have the authority to establish policies, allocate resources, or make decisions. That is power. But having power does not necessarily mean being able to influence others or bring about the desired change.</p><p>This is where leverage becomes important.</p><h3><strong>From Power to Leverage</strong></h3><p>In the context of leadership, power can be understood as the ability or authority to act. Leverage, meanwhile, refers to the bargaining position that enables someone to use that power to influence decisions or circumstances.</p><p>The two are closely related, but they do not always go hand in hand.</p><p>In one scene from Animals, Dayle explains that leverage can emerge from the balance between incentives and consequences. In simple terms, it is about understanding what we can offer to encourage another party to cooperate and what consequences they may realistically face if an agreement cannot be reached.</p><p>Interestingly, someone&#39;s bargaining position may change not because they have gained more power, but because their circumstances and level of dependence have changed.</p><p>This becomes apparent when Mark Kimball, the film&#39;s main character, discovers that the kidnapped child is not actually his own son. This change in circumstances reduces the emotional pressure that had previously influenced his ability to make decisions. According to Dayle, the situation actually strengthens Mark&#39;s bargaining position in dealing with the kidnappers.</p><p>Of course, this situation also presents a moral dilemma. Reduced pressure on one individual does not mean that another person&#39;s safety or life becomes any less important.</p><p>From this scene, I take away one important lesson: <strong>strength is not always determined by how much power someone possesses, but also by their ability to understand circumstances, dependencies, and available choices.</strong></p><h3><strong>Why Can Alternatives Strengthen Bargaining Power?</strong></h3><p>This observation led me to explore the concept of the Best Alternative to a Negotiated Agreement, or BATNA, introduced by Roger Fisher and William Ury in their book Getting to Yes: Negotiating Agreement Without Giving In, first published in 1981.</p><p>Simply put, BATNA refers to the best alternative available when a negotiation does not result in an agreement.</p><p>This concept helps explain why a party that appears stronger does not necessarily hold a better negotiating position.</p><p>Consider a distribution company negotiating a transportation contract. The company has substantial shipment volumes, a nationwide distribution network, and the authority to establish service standards.</p><p>From a resource perspective, the company possesses considerable power.</p><p>But what if, for certain products, particularly those requiring temperature-controlled or cold-chain handling, the company relies on only one transportation provider capable of meeting its quality and operational requirements?</p><p>Under such circumstances, the company&#39;s bargaining position may become limited because of its high level of dependence on that service provider.</p><p>Conversely, if the company has several alternative transportation providers that meet the required standards, possess sufficient capacity, and can realistically be engaged, its negotiating position becomes stronger.</p><p>The company gains greater flexibility to compare costs, service levels, and risks before making a decision. Naturally, these alternatives must continue to meet quality standards and regulatory compliance requirements.</p><p>This illustrates the relevance of BATNA. <strong>The stronger the alternatives that are genuinely available, the less dependent we become on a single agreement, and the greater our ability to make rational decisions.</strong></p><p>However, BATNA does not guarantee that every negotiation will succeed. It is one source of leverage that helps us determine when compromise is appropriate and when choosing an alternative may be the better decision.</p><h3><strong>When Leverage Is Not Enough: From Bargaining Power to Value Creation</strong></h3><p>Leverage is important because it provides room to negotiate, consider different options, and reduce dependence. However, having a strong bargaining position does not necessarily mean being able to achieve the best outcome for everyone involved.</p><p>In negotiation, there is a distinction between value claiming, which focuses on securing a share of existing value, and value creation, which seeks to generate additional value through collaboration. Both are complementary aspects of reaching effective agreements (Program on Negotiation Staff, 2026).</p><p>For example, a distribution company with strong bargaining power may succeed in negotiating lower transportation rates. However, greater value may be created when the company and its transportation providers work together to improve route efficiency, vehicle utilization, and service quality while reducing operational emissions.</p><p>This is where leverage should be used not merely to win negotiations, but also to create opportunities for collaboration.</p><p>Effective leaders are not simply those who can secure advantages. They also understand how their decisions can create sustainable value.</p><h3><strong>From Leverage to Outcome</strong></h3><p>A similar principle applies to leadership.</p><p>Imagine two leaders with the same level of authority.</p><p>The first leader uses their position to ensure that every instruction is followed. Decisions are made based on formal authority, and success tends to be measured by the degree of compliance with those instructions.</p><p>The second leader, meanwhile, uses their authority to build influence, understand the interests of different stakeholders, develop strategic alternatives, and encourage decisions that people can collectively support and implement.</p><p>Both possess power, but the way they develop and exercise leverage is different. Consequently, the outcomes they achieve may also differ.</p><p>Within an organization, power can enable a decision to be made. However, the ability to influence others, build support, and manage dependencies often determines whether that decision can be implemented effectively.</p><p>On the other hand, strong leverage does not always lead to the right decision.</p><p>There are situations in which someone successfully obtains what they want but does so at the expense of trust, professional relationships, or long-term interests.</p><p>Therefore, outcomes should not be evaluated solely by whether targets have been achieved, but also by the consequences of those decisions for the organization and the people involved.</p><h3><strong>When Power Must Be Balanced with Wisdom</strong></h3><p>For me, the relationship between power, leverage, and outcome is not merely about negotiation techniques or the ability to advance one&#39;s interests.</p><p>There is a broader lesson about how leaders exercise their authority.</p><p>Power provides the capacity to act. Leverage helps establish a stronger position from which to influence decisions. Yet the final outcome still depends on the judgment, actions, and sense of responsibility of the person exercising that power.</p><p>In this context, having alternatives is not simply about strengthening one&#39;s bargaining position.</p><p>Alternatives also give leaders the space to avoid accepting circumstances too hastily, consider potential risks, and make decisions based on more objective assessments.</p><p>The conversation in Animals led me to one reflection:</p><p>Power is what you hold. Leverage is how you use it. Outcomes reveal the quality of your leadership.</p><p>Power represents what we possess. Leverage reflects how we put it to use. Outcomes, meanwhile, become a reflection of the decisions we make.</p><p>Ultimately, leaders do not become strong simply because they possess substantial authority.</p><p>Leadership strength is also demonstrated through the ability to exercise that authority appropriately, recognize limitations, and develop alternatives that enable better decisions.</p><p>And perhaps the question worth reflecting on is no longer how much power we possess, but rather:</p><p>How wisely do we transform power into influence, and influence into outcomes for which we can be held accountable?</p><p>This article represents my personal reflections and perspectives, developed from the references cited and my understanding of the concepts discussed.</p><h3><strong>References</strong></h3><p>Affleck, B. (Director). (2026). Animals [Film]. Artists Equity; Fifth Season.</p><p>Fisher, R., Ury, W., &amp; Patton, B. (2011). Getting to yes: Negotiating agreement without giving in (3rd ed.). Penguin Books.</p><p>PON Staff. (2022, December 22). Business negotiation strategies for managing the tension between claiming and creating value. Program on Negotiation at Harvard Law School. https://www.pon.harvard.edu/daily/batna/manage-the-tension-between-claiming-and-creating-value-nb/</p><p>https://www.pon.harvard.edu/daily/batna/manage-the-tension-between-claiming-and-creating-value-nb/</p><p>PON Staff. (2026, July 7). The negotiator&#39;s dilemma: How MESOs help you create and claim value. Program on Negotiation at Harvard Law School.</p><p>https://www.pon.harvard.edu/daily/negotiation-skills-daily/managing-the-negotiators-dilemma-nb/</p><p>Program on Negotiation at Harvard Law School. (n.d.). What is getting to yes?</p><p>https://www.pon.harvard.edu/tag/getting-to-yes/</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=59ffb0f552fe" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[“Delivering Medicines, While Learning to Reduce the Carbon Footprint”]]></title>
            <link>https://medium.com/@esukandar1608/delivering-medicines-while-learning-to-reduce-the-carbon-footprint-ba0a6cfa8354?source=rss-3b72b6ef4763------2</link>
            <guid isPermaLink="false">https://medium.com/p/ba0a6cfa8354</guid>
            <category><![CDATA[carbon-emissions]]></category>
            <category><![CDATA[logistics]]></category>
            <category><![CDATA[sustainability]]></category>
            <category><![CDATA[supply-chain-management]]></category>
            <category><![CDATA[decarbonization]]></category>
            <dc:creator><![CDATA[Endang Sukandar]]></dc:creator>
            <pubDate>Mon, 26 Oct 2026 02:56:03 GMT</pubDate>
            <atom:updated>2026-10-26T02:56:03.989Z</atom:updated>
            <content:encoded><![CDATA[<p>Experience-Based Reflective Article by Endang Sukandar</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/400/0*t6jXLW4X_VRdw0DU.jpeg" /><figcaption>EV Fleet Delivery of PT Anugrah Argon Medica (AAM)</figcaption></figure><p><a href="https://kumparan.com/endang-sukandar/mengantar-obat-sambil-belajar-mengurangi-jejak-karbon-28Q2Nv8J8ki"><strong>Have you ever wondered how many journeys it takes for a medicine to reach a pharmacy, clinic, or hospital?</strong> </a>Behind the seemingly ordinary activities of healthcare logistics, there is an environmental issue that has increasingly caught my attention: how much carbon emission is generated from each delivery? For most people, what matters most is that the medicine is available when needed. Not late, in good condition, and of course, safe to use. I used to think that way too. Working in healthcare logistics and distribution, I was accustomed to seeing delivery activities as a part of daily operational routines. There are orders to process, vehicles to dispatch, and customers waiting for their shipments. Every day, thousands of packages of medicines and medical devices move through the distribution network. Behind every shipment, many people work to ensure everything runs smoothly. However, lately, one question has been popping up in my mind more and more frequently. How much energy do we use, and how much carbon emission is generated, to ensure all those deliveries reach their destinations? This simple question has led me to see my daily work from a completely different perspective.</p><p><strong>When Business Grows, Something Else Increases Too</strong></p><p>In the logistics world, growth in delivery volume is usually welcoming news. It means business activity is increasing, the service network is expanding, and more customer needs are being met. Where I work, at PT Anugrah Argon Medica (AAM), which is part of PT Medela Potentia Tbk (MDLA), internal operational records show an increase in distribution volume of about 26% throughout 2023–2025. Of course, there are many positive aspects to this growth. However, the more products shipped, the more activities are required. Vehicles make trips, warehouses use electricity, cooling facilities run constantly, and various other resources are consumed. I began to wonder, must an increase in activity always be followed by a proportional increase in energy use and emissions? Or is there actually a way to work more efficiently without compromising service quality? This is where my interest in decarbonization began to grow. Initially, I imagined that reducing logistics emissions was mainly about replacing petrol or diesel vehicles with electric ones. It turns out the issue is much broader.</p><p><strong>Turns out, Vehicles Aren’t the Only Ones Generating Emissions</strong></p><p>I learned something fascinating when I started diving into the company’s emission data. When we talk about pollution from logistics activities, the most common image that comes to mind is delivery vehicles on the highway. I used to think the same way. However, looking at the 2025 internal emission inventory results, I found something that changed my perspective entirely. About 61% of the emission footprint within the reviewed inventory scope actually came from electricity consumption, known as Scope 2. Meanwhile, direct emissions from the company’s fleet only accounted for about 6%. This figure was quite intriguing to me. It does not mean vehicles are not important. In fact, they remain an area that needs improvement. But it turns out the largest source of emissions does not always come from the most visible activity. Warehouses need lighting. Cooling systems must maintain storage temperatures. Operational equipment uses electricity almost around the clock. Not to mention transport activities by partner companies that are also part of the distribution chain. I then understood that the carbon footprint of a delivery does not just start when the vehicle heads to the customer. Energy is consumed long before the vehicle leaves the warehouse. Since then, I have become increasingly convinced that reducing emissions must start with understanding where they come from. We cannot fix something accurately if we do not truly know what needs to be fixed. It sounds simple, but in practice, it is not always easy.</p><p><strong>Reducing Emissions, but Medicines Must Remain Safe</strong></p><p>There is one thing that makes working in healthcare distribution quite different from general logistics. We do not just ship goods. The products we deliver are used to support healthcare services, and under certain conditions, they directly relate to patient safety. Therefore, efficiency cannot be carried out carelessly. For instance, some products must be stored and shipped within a specific temperature range. These products require special handling to maintain their quality. In pharmaceutical distribution, the principles of Good Distribution Practice (GDP/CDOB) are an essential part of daily work. Imagine if we were too eager to save electricity, but ended up compromising the temperature stability of medicine storage. Or if we wanted to reduce vehicle trips, but deliveries became delayed and service quality dropped. Surely, that is not what we want. For me, the real challenge is not just how to reduce emissions as much as possible. The challenge is how to reduce emissions while maintaining product quality, service reliability, and patient safety. That is why not all changes can be made instantly. Things must be calculated, tested, evaluated, and then improved before being implemented more widely. Sometimes the process is indeed slower than we hope. However, I believe that carefully executed changes are more likely to endure in the long run.</p><p><strong>Learning from Small Things on the Ground</strong></p><p>One of the things I love about the operational world is the abundance of improvement opportunities right around us. Not everything requires a large investment or complex technology. I began to realize that many opportunities to reduce emissions actually arise from daily routines. Sometimes it is as simple as noticing a vehicle leaving with an sub-optimal load, rethinking delivery routes, or looking at how electricity is used in the warehouse. Things I used to view merely as operational efficiency issues turn out to have a close connection with the environment. Through data utilization, route optimization technology, and fleet management systems like Cartrack, we try to understand vehicle travel patterns better. The goal is not only to speed up deliveries but also to reduce less productive trips. On the other hand, there are also efforts to improve driving habits through Eco &amp; Safety Driving training. A total of 239 drivers across 20 branches have participated in this training. For me, programs like this are interesting because the benefits go beyond the environment. Better driving is also related to safety, fuel consumption, and vehicle maintenance. The same applies to the warehouse. Using LED lights, inverter ACs, and evaluating more efficient cooling systems might not sound spectacular. But when implemented consistently across many facilities, these small improvements can become an essential part of a larger change. I learned that sustainability is actually very close to discipline in performing daily tasks.</p><p><strong>When Electric Vehicles Start Becoming Part of the Delivery</strong></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/400/0*SFEhVp86qRWW3Qud.jpeg" /><figcaption>The pilot project for the EV fleet was officially launched in December 2022</figcaption></figure><p>One of the developments that is quite exciting for me is the introduction of electric vehicles in distribution activities. A few years ago, we might have seen electric vehicles more often as a topic of discussion about the future of transportation. Now, their use is becoming a reality in operational activities. In the distribution network where I work, electric motorbikes are being used to support last-mile deliveries. On April 11, 2026, the company also launched its first electric car for distribution operations at AAM Jakarta 2. Based on developments published up to September 2026, as many as 107 electric vehicles, consisting of motorbikes and cars, have been deployed across 15 branches in 13 cities. For me, this is certainly an encouraging development. However, there is one thing I think is important to remember. Owning electric vehicles does not automatically make the entire distribution process low-carbon. We still have to consider travel distance, payload capacity, driver capability, charging availability, and even the source of electricity used. Not every type of vehicle is suitable for all regions or delivery needs. Therefore, I see electrification more as a journey of learning, rather than just a race to increase the number of electric vehicles. Technological change needs to be accompanied by the readiness of the system and the people who use it.</p><p><strong>Warehouse Electricity and Lessons from Solar Panels</strong></p><p>Knowing that electricity consumption is one of the largest contributors to emissions, my attention turned even more to energy use in operational facilities. One of the steps taken by the company is the installation of rooftop solar panels at the Tangerang branch with an installed capacity of over 90 kWp. I see this initiative as an important step toward reducing dependence on fossil-based electricity. However, there is an interesting lesson. Using renewable energy does not mean we can ignore energy efficiency. The best-managed electricity is still the electricity that is used appropriately. That is why measuring electricity consumption, regulating equipment usage, and evaluating cooling systems still need to be done. In healthcare distribution facilities, the principle remains the same: energy is used more wisely, but the storage quality of the products must never be sacrificed. Changes like this might not always be visible to customers. However, it is precisely behind the scenes that many opportunities for improvement can be found.</p><p><strong>Figures That Make Me Increasingly Optimistic</strong></p><p>After various efforts have been made, the next question naturally arises. Does it all really yield results? From measurements conducted by the company, the greenhouse gas emission intensity in 2025 was recorded to have dropped by about 20% compared to the 2023 baseline. Specifically, Scope 1 and Scope 2 emission intensities decreased by around 18%. Meanwhile, the average operational fuel cost also saw a 17% reduction compared to the 2024 baseline. Seeing these developments, I am quite optimistic that operational efficiency and sustainability can indeed go hand in hand. But I have also learned to be more cautious when reading figures. A decrease in emission intensity, for example, does not automatically mean the company’s total emissions have dropped. Intensity describes emissions relative to a specific unit of activity. When business volume continues to rise, the overall amount of emissions still needs to be checked separately. For me, this is exactly why good data is important. Numbers are not just material to showcase success. Numbers should help us understand what has improved, what has not, and what still needs to be done. I am increasingly convinced that a sustainability program is not enough if it only looks good in a presentation. It needs to deliver changes that can be measured and explained honestly.</p><p><strong>Turns out, Sustainability Is Also About the People Inside It</strong></p><p>The longer I am involved in various environmental activities, the more I realize that technology and investment are only part of the story. There is another equally important element: people. Drivers who strive to drive more efficiently, warehouse teams disciplined in energy use, to branch colleagues who help maintain data quality. Everyone contributes. I have also seen how simple activities can make environmental issues feel closer to daily life. For instance, through collaboration with Food Cycle Farm, more than 9.8 tons of food waste was successfully managed and repurposed as fish feed from May 2025 to April 2026. There was also a tree-planting activity of 750 trees through the participation of 16 branches in 14 cities in January–February 2026. One of the interesting ones was the Walka-Walka program. Through a collective walking activity, more than 70 million steps collected by employees were turned into the planting of 700 mangrove trees on the Tangerang coast. I love the idea behind this activity. Something so simple, like walking, can turn out to be a way to get more people involved in environmental initiatives. Of course, planting trees is not a substitute for the obligation to reduce operational emissions. However, it can help build awareness and a sense of ownership toward a larger goal. I believe long-lasting change cannot just be driven by company policy. It also requires people who understand why it matters.</p><p><strong>Far from Over</strong></p><p>If asked whether this journey has succeeded, I would probably answer that we are still learning. There are developments to be grateful for, but there is still a lot of work to be done. I am also grateful to be part of the company’s journey, which received recognition through the IDX Channel ESG Award in 2025 and 2026. However, awards are not the end of the journey. There are still long-term targets to pursue, including the ambition to reduce emission intensity by up to 52% by 2030, expanding electric vehicles to 50% of the operational fleet, and achieving Net Zero for Scope 1 and Scope 2 operational emissions by 2050. These targets are certainly not simple. Moreover, healthcare distribution activities continue to grow and involve many parties, including transport partners, technology providers, suppliers, and facility managers. I also realize that not all solutions are suitable to be applied the same way in every location. What works in one branch won’t necessarily yield the same results in another. Therefore, the approach that makes the most sense to me is to keep trying, measuring, learning, and improving. One successful step can be the start of the next one.</p><p><strong>In the End, It All Comes Back to One Shipment</strong></p><p>There is one thought that has grown stronger within me after going through this process. In the past, when talking about distribution success, my attention was mostly focused on whether products were delivered on time, whether services ran well, and whether operational costs remained controlled. All of that is still very important. However, now I am starting to add one question. Can we provide the same good service with more efficient resource use and a smaller environmental impact? I believe the answer is yes, even though the path is not always easy. Not all changes have to start with big investments or advanced technology. Sometimes change begins with a slightly more efficient delivery route, wiser electricity use, better driving habits, or a simple decision not to make a trip that isn’t actually necessary. When done consistently by many people, those small steps can turn into something meaningful. For me, decarbonizing healthcare logistics is not just about emission figures or replacing conventional vehicles with electric ones. It is about how we keep learning to provide better service, in a way that is increasingly responsible to the environment. Because in the end, our goal remains the same: ensuring medicines and medical devices reach the people who need them. Only now, we are also trying to pay attention to the environmental footprint left behind in every journey. One shipment at a time. And I think the journey to become better will still continue.</p><p><strong><em>This text represents my personal reflection and views based on my experience in the field of logistics operations and sustainability, as well as information available up to October 2026. All views expressed do not constitute an official statement of the company.</em></strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=ba0a6cfa8354" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Scenario Planning dan AHP untuk Future Readiness Healthcare Distributor]]></title>
            <link>https://medium.com/@esukandar1608/scenario-planning-dan-ahp-untuk-future-readiness-healthcare-distributor-54e3362f9019?source=rss-3b72b6ef4763------2</link>
            <guid isPermaLink="false">https://medium.com/p/54e3362f9019</guid>
            <category><![CDATA[farmasi]]></category>
            <category><![CDATA[strategic-planning]]></category>
            <category><![CDATA[esg]]></category>
            <category><![CDATA[pharma-distributor]]></category>
            <dc:creator><![CDATA[Endang Sukandar]]></dc:creator>
            <pubDate>Fri, 16 Oct 2026 10:25:45 GMT</pubDate>
            <atom:updated>2026-10-16T10:25:45.575Z</atom:updated>
            <content:encoded><![CDATA[<p>Oleh Endang Sukandar</p><h3>Abstrak</h3><p>Paper ini menyimpulkan bahwa skenario <strong>S2 — Smart Regulated Network</strong> adalah arah kesiapan masa depan paling kokoh bagi sebuah Healthcare Distributor berskala nasional di Indonesia untuk horizon 2026–2032, dengan bobot global AHP 0,391 dibanding 0,359 untuk S1 — Compliance Trap. Analisis menggabungkan <em>scenario planning</em> model Oxford/Shell dengan <em>Analytic Hierarchy Process</em> (AHP) Saaty. Dua <em>driver</em> dengan dampak dan ketidakpastian tertinggi, yaitu penegakan regulasi &amp; ESG serta adopsi digital &amp; AI dalam logistik, membentuk matriks 2×2 berisi empat skenario.</p><p>Lima domain kapabilitas dinilai berpasangan oleh panel ahli lintas fungsi: Compliance (49,3%), Digital (22,4%), Network (14,1%), Service (8,8%) dan Cost (5,4%). Seluruh matriks konsisten (CR 0,016–0,044, di bawah ambang 0,10). Uji sensitivitas menunjukkan keunggulan S2 bertahan selama bobot Compliance di bawah sekitar 54%; di atas titik itu S1 mengambil alih. Implikasinya, Healthcare Distributor perlu menyeimbangkan kepatuhan dengan transformasi digital-jaringan melalui empat <em>no-regret moves</em> dan peta jalan tiga fase, dengan potensi penghematan biaya transportasi 12–15% atau sekitar Rp9,0–11,3 miliar per tahun pada 2032 untuk distributor representatif berpenjualan Rp10 triliun.</p><h3>1. Pendahuluan</h3><h3>1.1 Latar belakang</h3><p>Objek studi adalah sebuah Healthcare Distributor, yaitu distributor farmasi dan alat kesehatan berskala nasional dengan jaringan logistik berstandar CDOB, termasuk rantai dingin (<em>cold chain</em>) dengan integritas suhu ketat. Identitas perusahaan disamarkan, dan seluruh angka finansial dalam paper ini memakai acuan umum industri, bukan data perusahaan. Distribusi farmasi adalah bisnis bervolume besar dengan margin sangat tipis: distributor farmasi di Amerika Serikat, misalnya, hanya mencatat margin laba bersih sekitar 0,2% dari pendapatan pada 2024, turun dari 0,3% pada 2023 dan menandai tahun kesebelas kompresi margin berturut-turut (HDA Research Foundation, 2025 dalam <a href="https://chaindrugreview.com/pharmaceutical-distributors-report-growth-despite-tight-margins">Chain Drug Review, 2025</a>). Dengan margin setipis itu, efisiensi operasional, bukan volume, menjadi sumber nilai utama.</p><p>Lingkungan bisnis distribusi farmasi Indonesia sedang berubah dari beberapa arah sekaligus:</p><p>• <strong>Regulasi makin ketat.</strong> BPOM menerbitkan Peraturan BPOM №20 Tahun 2025 tentang CDOB yang menggantikan Peraturan №9 Tahun 2019. Cakupannya kini meliputi distribusi elektronik B2B, aturan <em>cold chain</em> yang lebih rinci, ketertelusuran dari produsen ke konsumen, serta sanksi hingga pencabutan sertifikat (<a href="https://news.sah.co.id/standar-cara-distribusi-obat-yang-baik-cdob/?amp=1">SAH, 2025</a>).</p><p>• <strong>Kewajiban halal bertahap.</strong> Berdasarkan PP №42 Tahun 2024, kewajiban halal untuk obat bahan alam, obat kuasi dan suplemen berlaku 17 Oktober 2026; obat bebas dan bebas terbatas 17 Oktober 2029; obat keras 17 Oktober 2034 (<a href="https://bpjph.halal.go.id/read/bpjph-dorong-industri-farmasi-bersiap-sambut-wajib-halal-oktober-2026">BPJPH, 2025</a>). Ketertelusuran halal menambah beban data di sepanjang rantai pasok.</p><p>• <strong>Biaya logistik tinggi.</strong> Biaya logistik nasional masih sekitar 14,29% dari PDB menurut Kementerian Perhubungan (<a href="https://rri.co.id/en/national/2379761/indonesia-pushes-multimodal-logistics-to-cut-costs-at-1429-percent-gdp">RRI, 2026</a>). Skor <em>Logistics Performance Index</em> Indonesia turun dari 3,15 (peringkat 46, 2018) menjadi 3,0 (peringkat 63 dari 139, 2023) (<a href="https://pwc.com/id/en/media-centre/infrastructure-news/august-2023/logistics-performance-lessons-learned-for-indonesia.html">PwC Indonesia, 2023</a>).</p><p>• <strong>Tekanan karbon.</strong> UU Harmonisasi Peraturan Perpajakan (2021) telah memperkenalkan pajak karbon dengan tarif usulan Rp30/kg CO₂e, tetapi perluasan ke sektor di luar PLTU belum dipastikan (<a href="https://pajakku.com/artikel/ketentuan-pajak-karbon-indonesia-contoh-hitungnya">Pajakku, 2024</a>). Ketidakpastian ini justru menjadikannya variabel skenario.</p><p>• <strong>Digitalisasi dan model pengiriman baru.</strong> Kanal online baru sekitar 10% dari penjualan obat generik, dengan rumah sakit 60% dan apotek ritel 30% (IQVIA 2023 dalam <a href="https://ekonomi.bisnis.com/read/20240629/257/1778018/opini-menguak-potensi-industri-farmasi-indonesia">Bisnis.com, 2024</a>). Porsi kecil dengan potensi tumbuh tinggi inilah yang membuka ruang <em>direct-to-patient</em> dan pemain <em>tech-native</em>.</p><h3>1.2 Rumusan masalah</h3><p>Paper ini menjawab tiga pertanyaan strategis fokus:</p><p>1. Masa depan apa saja yang masuk akal (<em>plausible</em>) membentuk Healthcare Distributor hingga 2032?</p><p>2. Seberapa siap kapabilitas Healthcare Distributor menghadapi masing-masing masa depan tersebut?</p><p>3. Lintasan kapabilitas mana yang paling kokoh untuk diprioritaskan di bawah ketidakpastian?</p><h3>1.3 Tujuan dan ruang lingkup</h3><p>Tujuannya adalah merumuskan arah transformasi yang paling kokoh, bukan meramalkan satu masa depan. Unit analisis adalah ekosistem distribusi farmasi dan alat kesehatan Indonesia, mencakup logistik rantai dingin, lingkungan regulasi dan struktur jaringan. Horizon waktu 2026–2032 dipilih agar mencakup pergeseran operasional jangka pendek sekaligus evolusi struktur pasar.</p><h3>2. Tinjauan Pustaka dan Kerangka Teori</h3><h3>2.1 Scenario planning</h3><p><em>Scenario planning</em> adalah cara menyusun beberapa gambaran masa depan yang masuk akal untuk menguji strategi, bukan untuk meramal. Pendekatan ini berakar pada praktik Royal Dutch Shell tahun 1970-an yang dipopulerkan Wack (1985) dan disistematiskan oleh Schwartz (1991) serta van der Heijden (2005). Schoemaker (1995) menunjukkan bahwa skenario efektif untuk lingkungan dengan ketidakpastian tinggi dan kemampuan prediksi rendah. Ramirez dan Wilkinson (2016) melalui <em>Oxford Scenario Planning Approach</em> menekankan skenario sebagai alat <em>reframing</em>: membantu manajemen melihat asumsi yang selama ini tidak dipertanyakan.</p><p>Courtney, Kirkland dan Viguerie (1997) membagi ketidakpastian ke dalam empat level. Distribusi farmasi Indonesia 2026–2032 berada pada level 2–3 (<em>alternate futures</em> hingga <em>range of futures</em>), sehingga satu ramalan tunggal tidak memadai dan skenario 2×2 menjadi pilihan yang tepat.</p><p>Tahapan yang dipakai dalam paper ini mengikuti siklus empat langkah:</p><p>1. <strong>Sensing</strong> — memindai sinyal ESG, regulasi dan teknologi logistik.</p><p>2. <strong>Sensemaking</strong> — mengelompokkan sinyal menjadi klaster <em>driver</em>.</p><p>3. <strong>Scenario building</strong> — menyilangkan dua <em>driver</em> kritis menjadi matriks 2×2 dan menyusun narasinya.</p><p>4. <strong>Experimentation</strong> — menguji strategi dan kapabilitas di setiap skenario.</p><h3>2.2 Pemindaian lingkungan (PESTEL/STEEP)</h3><p>Sinyal lingkungan dipindai dengan kerangka PESTEL (politik, ekonomi, sosial, teknologi, lingkungan, legal). Sinyal kemudian dipilah menjadi tiga lapis menurut tingkat kepastiannya: <em>early signals</em> (tanda awal), <em>confirmed trends</em> (tren yang sudah berjalan) dan <em>critical uncertainties</em> (kekuatan berdampak tinggi yang arahnya belum pasti). Hanya lapis ketiga yang layak menjadi sumbu skenario, karena tren yang sudah pasti akan muncul di semua skenario.</p><h3>2.3 Analytic Hierarchy Process (AHP)</h3><p>AHP dikembangkan Saaty (1980) untuk keputusan multikriteria yang melibatkan penilaian kualitatif. Masalah diurai menjadi hierarki (tujuan, kriteria, subkriteria, alternatif), lalu setiap pasangan elemen dibandingkan dengan skala 1–9. Bobot prioritas diperoleh dari <em>eigenvector</em> matriks perbandingan, dan logika penilaian diuji dengan <em>Consistency Ratio</em> (CR):</p><p>Matriks dianggap konsisten bila CR ≤ 0,10 (Saaty, 1990). Untuk penilaian kelompok, Forman dan Peniwati (1998) merekomendasikan agregasi dengan rata-rata geometrik karena mempertahankan sifat resiprokal matriks. Vaidya dan Kumar (2006) mencatat AHP sebagai salah satu metode multikriteria yang paling banyak dipakai dalam logistik, pemilihan pemasok dan perencanaan strategis.</p><h3>2.4 Future readiness dan kapabilitas dinamis</h3><p>Konsep <em>future readiness</em> berangkat dari teori kapabilitas dinamis Teece, Pisano dan Shuen (1997): keunggulan bersaing bertahan bila perusahaan mampu merasakan (<em>sensing</em>), menangkap (<em>seizing</em>) dan mentransformasi (<em>transforming</em>) sumber dayanya. Rohrbeck dan Kum (2018) menemukan bahwa perusahaan dengan kesiapan masa depan tinggi mencatat profitabilitas 33% lebih tinggi dan pertumbuhan kapitalisasi pasar 200% lebih tinggi dibanding rata-rata. Dalam konteks rantai pasok, Christopher (2016) menegaskan bahwa ketahanan (<em>resilience</em>) dan visibilitas end-to-end menjadi sumber diferensiasi utama.</p><h3>2.5 Kerangka konseptual penelitian</h3><p>Paper ini menggabungkan dua metode secara berurutan. <em>Scenario planning</em> menjawab “masa depan apa yang mungkin terjadi”, sementara AHP menjawab “profil kapabilitas mana yang paling siap menghadapinya”. Kombinasi skenario dan analisis multikriteria seperti ini lazim dalam literatur <em>scenario-based MCDA</em> (Stewart, French dan Rios, 2013), karena skenario menyediakan konteks dan AHP menyediakan ketegasan kuantitatif.</p><h3>3. Metodologi</h3><h3>3.1 Desain penelitian</h3><p>Penelitian ini bersifat kualitatif-kuantitatif (<em>mixed method</em>) dengan dua tahap. Tahap pertama, <em>scenario planning</em>, menghasilkan empat skenario dari dua <em>driver</em> kritis. Tahap kedua, AHP, menilai kesesuaian kapabilitas Healthcare Distributor terhadap tiap skenario.</p><h3>3.2 Pemilihan driver skenario</h3><p>Dari 15 sinyal yang dipindai, dua <em>driver</em> dipilih dengan empat kriteria: (1) dampak tinggi terhadap struktur biaya, risiko kepatuhan dan posisi bersaing; (2) ketidakpastian tinggi atas arah perkembangannya; (3) membentuk sistem, yaitu memengaruhi jaringan, model layanan dan model operasi sekaligus; (4) membedakan skenario secara tegas.</p><h3>3.3 Struktur hierarki AHP</h3><p>Hierarki disusun dalam empat level:</p><p>1. <strong>Level 1 — Tujuan:</strong> menilai kesiapan masa depan Healthcare Distributor di empat skenario.</p><p>2. <strong>Level 2 — Kriteria (domain kapabilitas):</strong> Compliance, Digital, Network, Service, Cost.</p><p>3. <strong>Level 3 — Subkriteria:</strong></p><p>o Compliance: kepatuhan CDOB/GDP, <em>tracking &amp; traceability</em>, pelaporan</p><p>o Digital: AI <em>routing</em>, <em>demand forecasting</em>, otomasi gudang</p><p>o Network: multimoda, optimasi <em>hub</em>, <em>dynamic routing</em></p><p>o Service: OTIF, <em>lead time</em>, akurasi</p><p>o Cost: efisiensi BBM, biaya per pengiriman/<em>drop</em>, optimasi muatan</p><p>4. <strong>Level 4 — Alternatif:</strong> S1 Compliance Trap, S2 Smart Regulated Network, S3 Wild Competitive Market, S4 Digital Disruption Arena.</p><h3>3.4 Skala penilaian dan panel ahli</h3><p><strong>Nilai</strong></p><p><strong>Tingkat kepentingan</strong></p><p><strong>Keterangan</strong></p><p>1</p><p>Sama penting</p><p>Kedua elemen berkontribusi setara</p><p>3</p><p>Sedikit lebih penting</p><p>Penilaian sedikit memihak satu elemen</p><p>5</p><p>Lebih penting</p><p>Penilaian kuat memihak satu elemen</p><p>7</p><p>Sangat lebih penting</p><p>Dominasi terbukti dalam praktik</p><p>9</p><p>Mutlak lebih penting</p><p>Bukti dominasi pada tingkat tertinggi</p><p>2, 4, 6, 8</p><p>Nilai antara</p><p>Kompromi di antara dua nilai di atas</p><p>Sumber: Saaty (1980).</p><p>Penilaian berpasangan diberikan oleh panel ahli lintas fungsi: Compliance/QA, Operations/Supply Chain, Digital/IT, Commercial/Customer Service serta Finance/Strategy. Penilaian individu diagregasi dengan rata-rata geometrik (Forman &amp; Peniwati, 1998). Bobot dihitung dengan metode normalisasi kolom, lalu diverifikasi dengan <em>eigenvector</em> utama; kedua metode menghasilkan λmax yang sama (5,078) untuk matriks kriteria.</p><h3>3.5 Uji konsistensi dan sensitivitas</h3><p>Setiap matriks diuji dengan CR, menggunakan <em>Random Index</em> 0,90 untuk n = 4 dan 1,12 untuk n = 5. Ketahanan hasil diuji dengan analisis sensitivitas satu arah: bobot Compliance digeser dari 20% hingga 70%, sementara empat kriteria lain disesuaikan secara proporsional.</p><h3>3.6 Catatan metodologis</h3><p>Dalam AHP klasik, alternatif adalah opsi yang dapat dipilih. Di sini alternatifnya adalah skenario, yaitu kondisi eksternal yang tidak sepenuhnya dikendalikan perusahaan. Karena itu, hasil AHP dibaca sebagai <strong>profil kapabilitas atau postur strategis yang paling selaras dengan tiap skenario</strong>, bukan sebagai “memilih masa depan”. Dengan tafsir ini, “memilih S2” berarti membangun kapabilitas yang menjadikan perusahaan pemenang bila S2 terjadi, sekaligus menekan peluang terseret ke S1 atau tersisih di S4.</p><h3>4. Analisis Lingkungan dan Driving Forces</h3><h3>4.1 Dari sinyal ke ketidakpastian kritis</h3><p>Pemindaian menghasilkan 15 sinyal yang dipilah ke tiga lapis (layer) berikut.</p><p><strong>Lapis (Layer)</strong></p><p><strong>Sinyal</strong></p><p><strong>Dimensi PESTEL</strong></p><p>Early signals</p><p>Ketertelusuran farmasi berbasis <em>blockchain</em></p><p>Teknologi</p><p>Early signals</p><p>Pemantauan suhu IoT skala besar</p><p>Teknologi</p><p>Early signals</p><p>Konsolidasi pembelian grup rumah sakit</p><p>Ekonomi</p><p>Early signals</p><p>Uji coba AI untuk <em>routing</em> dan <em>forecasting</em></p><p>Teknologi</p><p>Early signals</p><p>Pergeseran ke distribusi <em>direct-to-patient</em></p><p>Sosial</p><p>Confirmed trends</p><p>Naiknya permintaan layanan kesehatan (biologik, vaksin)</p><p>Sosial</p><p>Confirmed trends</p><p>Digitalisasi rantai pasok</p><p>Teknologi</p><p>Confirmed trends</p><p>Tumbuhnya kebutuhan <em>cold chain</em></p><p>Teknologi/Ekonomi</p><p>Confirmed trends</p><p>Tekanan margin dari prinsipal</p><p>Ekonomi</p><p>Confirmed trends</p><p>Ekspektasi pengiriman cepat/<em>express</em></p><p>Sosial</p><p>Critical uncertainties</p><p>Intensitas penegakan CDOB dan ESG</p><p>Legal/Politik</p><p>Critical uncertainties</p><p>Kecepatan adopsi AI dan otomasi logistik</p><p>Teknologi</p><p>Critical uncertainties</p><p>Dorongan regulasi ketertelusuran dan farmasi halal</p><p>Legal</p><p>Critical uncertainties</p><p>Arah pajak karbon dan kebijakan logistik hijau</p><p>Lingkungan/Legal</p><p>Critical uncertainties</p><p>Masuknya pemain logistik berbasis teknologi</p><p>Ekonomi/Teknologi</p><p>Beberapa ketidakpastian kini punya penanda faktual. CDOB 2025 sudah memperluas cakupan ke distribusi elektronik dan <em>cold chain</em>, tetapi intensitas audit dan penegakannya masih bergantung pada kapasitas BPOM. Kewajiban halal obat sudah berjadwal hingga 2034, namun ketentuan ketertelusurannya di tingkat distributor belum rinci. Pajak karbon sudah berdasar hukum, tetapi perluasannya ke transportasi belum diputuskan.</p><h3>4.2 Empat klaster driver</h3><p>Sinyal dikelompokkan menjadi empat klaster:</p><p><strong>Klaster</strong></p><p><strong>Isi/Deskripsi</strong></p><p><strong>Yang dipertaruhkan</strong></p><p>Regulatory Pressure</p><p>CDOB, ESG, ketertelusuran halal, penegakan audit</p><p>Izin usaha (<em>license to operate</em>)</p><p>Digital Logistics Maturity</p><p>AI <em>routing</em>, integrasi WMS/TMS, otomasi gudang</p><p>Skala, kecepatan dan relevansi</p><p>Delivery Model Shift</p><p><em>Direct-to-patient</em>, pengiriman mendesak, ePOD</p><p>Logika layanan pelanggan</p><p>Cost &amp; Sustainability Pressure</p><p>BBM, tol, karbon, armada hijau</p><p>Margin dan posisi ESG</p><h3>4.3 Dua driver terpilih</h3><p><strong>Driver 1 — Penegakan regulasi &amp; ESG</strong> bergerak dari penegakan minimal dan kepatuhan sukarela hingga standar CDOB dan ESG yang wajib, diaudit ketat dan bersanksi hukum. Klaster <em>Cost &amp; Sustainability</em> melebur ke driver ini karena tekanan karbon pada akhirnya ditentukan oleh regulasi.</p><p><strong>Driver 2 — Adopsi digital &amp; AI dalam logistik</strong> bergerak dari operasi manual yang terfragmentasi hingga AI <em>routing</em>, gudang otomatis dan visibilitas <em>real-time</em> di seluruh jaringan. Klaster <em>Delivery Model Shift</em> melebur ke driver ini karena model D2P dan ePOD bergantung pada kematangan digital.</p><p>Kedua driver relatif independen satu sama lain. Regulasi dapat menguat tanpa diikuti digitalisasi, dan sebaliknya, sehingga keempat kombinasinya benar-benar berbeda.</p><h3>5. Skenario Masa Depan Healthcare Distributor 2032</h3><p>Persilangan dua driver menghasilkan empat skenario yang semuanya diperlakukan setara masuk akal pada tahap ini. Daya tarik strategisnya baru dinilai pada tahap AHP.</p><p><strong>Matriks skenario 2×2 · 4 skenario dari 2 driver kritis</strong></p><p>S2 diberi warna aksen karena menjadi arah yang direkomendasikan pada Bagian 6; sumbu vertikal adalah penegakan regulasi, sumbu horizontal adalah adopsi digital.</p><p><strong>Skenario</strong></p><p><strong>Implikasi strategis bagi Healthcare Distributor</strong></p><p><strong>Logika kelayakan</strong></p><p>S1 — Compliance Trap</p><p>Berat di kepatuhan namun tidak efisien secara operasional</p><p>Hanya layak bila perusahaan mampu mengotomasi kepatuhan dengan biaya efisien</p><p>S2 — Smart Regulated Network</p><p>Berevolusi menjadi platform logistik terintegrasi berkinerja tinggi</p><p>Kepatuhan + digital + orkestrasi jaringan membentuk parit yang sulit ditiru</p><p>S3 — Wild Competitive Market</p><p>Bersaing pada volume dan efisiensi biaya</p><p>Jaringan ultra-efisien + diferensiasi layanan</p><p>S4 — Digital Disruption Arena</p><p>Berisiko kehilangan peran perantara dalam rantai nilai</p><p>Kapabilitas platform + integrasi ekosistem (API, data, visibilitas)</p><p>Narasi tiap skenario dapat dibaca sebagai cerita 2032:</p><p>• <strong>S1.</strong> BPOM memperketat audit CDOB berbasis data dan ketertelusuran halal mulai berlaku untuk obat bebas pada 2029. Distributor masih mengandalkan <em>checklist</em> kertas dan rute statis, sehingga biaya auditor, dokumentasi dan <em>rework</em> naik lebih cepat dari pendapatan.</p><p>• <strong>S2.</strong> Regulasi ketat justru menjadi penghalang masuk. Distributor yang sudah memiliki <em>control tower</em>, logger IoT dan pelaporan karbon per pengiriman menjadi mitra pilihan prinsipal global yang mensyaratkan ketertelusuran penuh.</p><p>• <strong>S3.</strong> Penegakan lemah membuka pasar bagi operator 3PL murah. Prinsipal menekan tarif, dan diferensiasi hanya tersisa pada OTIF dan kecepatan.</p><p>• <strong>S4.</strong> <em>Marketplace</em> farmasi dan pemain logistik berbasis AI menghubungkan prinsipal langsung ke apotek dan pasien. Distributor tanpa API dan data <em>real-time</em> tersisih menjadi penyedia gudang semata.</p><h3>6. Hasil AHP</h3><h3>6.1 Bobot kriteria</h3><p>Panel ahli menghasilkan model yang dipimpin kepatuhan: Compliance memegang hampir separuh bobot, disusul Digital sebagai tuas strategis berikutnya.</p><p><strong>Kriteria</strong></p><p><strong>Bobot</strong></p><p><strong>λᵢ</strong></p><p><strong>Tafsir</strong></p><p>Compliance</p><p>0,493</p><p>5,16</p><p>Penentu utama; mencerminkan pola pikir <em>regulatory-first</em></p><p>Digital</p><p>0,224</p><p>5,12</p><p>Tuas transformasi jangka panjang</p><p>Network</p><p>0,141</p><p>5,05</p><p>Bobot struktural menengah</p><p>Service</p><p>0,088</p><p>5,01</p><p>Faktor operasional sekunder</p><p>Cost</p><p>0,054</p><p>5,05</p><p>Hampir tidak berpengaruh dalam model saat ini</p><p>Matriks kriteria sangat konsisten: λmax = 5,078, CI = 0,020, RI = 1,12, sehingga CR = 0,017.</p><h3>6.2 Prioritas lokal dan sintesis global</h3><p>Bobot global setiap skenario adalah jumlah perkalian bobot kriteria dengan prioritas lokal skenario pada kriteria tersebut.</p><p><strong>Skenario</strong></p><p><strong>Compliance (0,493)</strong></p><p><strong>Digital (0,224)</strong></p><p><strong>Network (0,141)</strong></p><p><strong>Service (0,088)</strong></p><p><strong>Cost (0,054)</strong></p><p><strong>Bobot global</strong></p><p><strong>Peringkat</strong></p><p>S2 — Smart Regulated Network</p><p>0,263</p><p><strong>0,558</strong></p><p><strong>0,519</strong></p><p><strong>0,558</strong></p><p>0,252</p><p><strong>0,391</strong></p><p>1</p><p>S1 — Compliance Trap</p><p><strong>0,558</strong></p><p>0,122</p><p>0,201</p><p>0,263</p><p>0,097</p><p>0,359</p><p>2</p><p>S3 — Wild Competitive Market</p><p>0,122</p><p>0,263</p><p>0,201</p><p>0,122</p><p>0,097</p><p>0,163</p><p>3</p><p>S4 — Digital Disruption Arena</p><p>0,057</p><p>0,057</p><p>0,079</p><p>0,057</p><p><strong>0,555</strong></p><p>0,087</p><p>4</p><p>Angka tebal menandai pemimpin tiap kriteria. S1 hanya memimpin satu kriteria, yaitu Compliance, yang menyumbang 0,275 dari total 0,359 bobot globalnya. S2 memimpin tiga kriteria berbobot menengah (Digital, Network, Service) dan tetap mendapat 0,130 dari Compliance, sehingga unggul 0,032 poin secara keseluruhan.</p><p>S3 digerakkan oleh logika efisiensi layanan dan biaya (Service dan Cost): pasar yang longgar regulasinya menghargai kecepatan dan tarif rendah. Namun pada kedua kriteria itu prioritas tertinggi tetap dipegang S2 (Service 0,558) dan S4 (Cost 0,555), sementara skor Compliance S3 yang rendah (0,122) menjadi kelemahan yang menentukan di pengadaan farmasi yang teregulasi.</p><h3>6.3 Konsistensi seluruh matriks</h3><p><strong>Matriks</strong></p><p><strong>n</strong></p><p><strong>λmax</strong></p><p><strong>CI</strong></p><p><strong>CR</strong></p><p><strong>Status</strong></p><p>Kriteria</p><p>5</p><p>5,078</p><p>0,020</p><p>0,017</p><p>Sangat baik</p><p>Alternatif terhadap Compliance</p><p>4</p><p>4,118</p><p>0,039</p><p>0,044</p><p>Konsisten</p><p>Alternatif terhadap Digital</p><p>4</p><p>4,118</p><p>0,039</p><p>0,044</p><p>Konsisten</p><p>Alternatif terhadap Network</p><p>4</p><p>4,044</p><p>0,015</p><p>0,016</p><p>Sangat baik</p><p>Alternatif terhadap Service</p><p>4</p><p>4,118</p><p>0,039</p><p>0,044</p><p>Konsisten</p><p>Alternatif terhadap Cost</p><p>4</p><p>4,044</p><p>0,015</p><p>0,016</p><p>Sangat baik</p><p>Seluruh CR berada di bawah 0,10, sehingga penilaian ahli dapat dipertanggungjawabkan secara logis.</p><h3>6.4 Analisis sensitivitas</h3><p>Keunggulan S2 bertahan selama bobot Compliance berada di bawah sekitar 54,2%, atau hanya 4,9 poin di atas bobot saat ini.</p><p>Dihitung dari matriks perbandingan berpasangan panel ahli · bobot Compliance 20–70%</p><p>Menurunkan bobot Compliance justru memperlebar keunggulan S2: pada Compliance 40% dan Digital 30% selisihnya menjadi 0,097, dan pada 35%/35% menjadi 0,134. Sebaliknya, jika panel menilai kepatuhan sedikit lebih dominan, peringkat S1 dan S2 berbalik. Artinya rekomendasi S2 kokoh terhadap pergeseran ke arah digital, tetapi rapuh terhadap pandangan yang lebih <em>regulatory-first</em>. S3 dan S4 tidak pernah mendekati posisi teratas pada rentang mana pun.</p><h3>7. Pembahasan dan Implikasi Strategis</h3><h3>7.1 Mengapa S2 unggul</h3><p>Keunggulan S2 yang ditunjukkan pada Bagian 6.2 sejalan dengan pandangan <em>resource-based view</em> (Barney, 1991): kombinasi kepatuhan yang terdigitalisasi, data <em>real-time</em> dan orkestrasi jaringan bersifat langka dan sulit ditiru. Kepatuhan manual (S1) mudah disamai pesaing besar, sedangkan kepatuhan yang tertanam dalam sistem menjadi parit bersaing.</p><p>Dari sisi kapabilitas dinamis (Teece dkk., 1997), S2 menuntut ketiga kemampuan sekaligus. <em>Sensing</em> lewat IoT dan <em>control tower</em>, <em>seizing</em> lewat AI <em>routing</em> dan otomasi, serta <em>transforming</em> lewat redesain jaringan dan model layanan D2P.</p><h3>7.2 Trade-off pilihan strategis</h3><p><strong>Pilihan</strong></p><p><strong>Yang dikorbankan</strong></p><p><strong>Penilaian</strong></p><p>Mengarah ke S2</p><p>Sebagian keunggulan kepatuhan dibanding S1 (0,263 vs 0,558 pada Compliance)</p><p>Dapat diterima karena ditukar dengan keunggulan digital dan jaringan</p><p>Bertahan di S1</p><p>Agilitas digital dan keunggulan jaringan</p><p>Mengunci perusahaan dalam inefisiensi struktural</p><p>Mengarah ke S3</p><p>Posisi kepatuhan</p><p>Risiko tinggi di pengadaan yang teregulasi; margin tergerus perang harga</p><p>S4 mendapat skor terendah, tetapi tetap penting karena mewakili ancaman disrupsi nyata dari pemain <em>tech-native</em>.</p><h3>7.3 Analisis kesenjangan kapabilitas</h3><p><strong>Domain</strong></p><p><strong>Kondisi saat ini</strong></p><p><strong>Target 2032</strong></p><p><strong>Kesenjangan terbesar</strong></p><p>Compliance</p><p>CDOB terpenuhi, sebagian besar manual dan berbasis kertas</p><p>Kepatuhan otomatis, siap audit <em>real-time</em>, tertelusur penuh</p><p>Integrasi digital dan pemantauan kepatuhan <em>real-time</em></p><p>Digital</p><p>WMS parsial, integrasi terbatas, <em>routing</em> manual</p><p><em>Control tower</em> AI dengan TMS/WMS/IoT terintegrasi dan analitik prediktif</p><p>Orkestrasi digital end-to-end dan analitik lanjutan</p><p>Network</p><p><em>Routing</em> statis, multimoda terbatas, jaringan terfragmentasi</p><p>Jaringan multimoda dinamis teroptimasi AI dengan optimasi <em>hub</em></p><p>Kecerdasan jaringan dan efisiensi rute</p><p>Service</p><p>OTIF dasar, manajemen layanan reaktif</p><p>Layanan prediktif, OTIF &gt;98%, visibilitas <em>real-time</em></p><p>Kapabilitas layanan proaktif</p><p>Cost</p><p>Pengendalian biaya reaktif</p><p>Biaya per <em>drop</em> teroptimasi lewat AI <em>routing</em> dan konsolidasi</p><p>Optimasi biaya sistematis dan pelacakan efisiensi</p><h3>7.4 Langkah strategis: no-regret moves dan scenario-leaning bets</h3><p>Mengikuti logika <em>robust strategy</em> (Schoemaker, 1995), langkah dibagi dua jenis.</p><p><strong>Jenis</strong></p><p><strong>Langkah</strong></p><p><strong>Isi</strong></p><p><strong>Relevansi skenario</strong></p><p>No-regret</p><p>CDOB (GDP) Digital Compliance &amp; Traceability</p><p>Sistem audit CDOB otomatis, logger IoT, peringatan kepatuhan <em>real-time</em></p><p>Semua</p><p>No-regret</p><p>AI Routing &amp; Transport Optimization</p><p><em>Dynamic routing</em>, konsolidasi muatan, optimasi moda; target biaya per <em>drop</em> turun 10–12% (2028) dan 15–20% (2032)</p><p>Semua</p><p>No-regret</p><p>Network Optimization</p><p>Redesain <em>hub</em>, rute multimoda, alokasi dinamis</p><p>Semua</p><p>No-regret</p><p>Digital Control Tower</p><p>Pemantauan OTIF, suhu dan biaya <em>real-time</em> di semua DC</p><p>Semua</p><p>Bet</p><p>ESG Acceleration</p><p>Armada EV, pelacakan CO₂ per pengiriman</p><p>S1, S2 (regulasi ESG kuat)</p><p>Bet</p><p>Advanced Automation</p><p><em>Picking</em> otomatis, sistem gudang berbasis AI</p><p>S2, S4 (digital tinggi)</p><p>Bet</p><p>Direct-to-Patient Platform</p><p>Distribusi berpusat pada pasien di luar B2B</p><p>S4 (disrupsi digital)</p><h3>7.5 Postur per skenario</h3><p><strong>Skenario</strong></p><p><strong>Postur</strong></p><p><strong>Alasan</strong></p><p>S2</p><p>Investasi agresif</p><p>Skor AHP tertinggi; target kondisi perusahaan</p><p>S4</p><p>Bangun pertahanan</p><p>Ancaman disintermediasi menuntut kesiapan platform dan API</p><p>S1</p><p>Hindari secara aktif</p><p>Biaya kepatuhan tanpa efisiensi digital menggerus margin; perusahaan bisa terseret ke sini karena tidak bertindak</p><p>S3</p><p>Perhatian minimal</p><p>Skor AHP terendah kedua; cukup dipantau</p><p>Postur ditetapkan dari skor AHP dan sifat ancaman tiap skenario, bukan dari probabilitas kejadiannya. Pendekatan ini konsisten dengan prinsip <em>scenario planning</em> bahwa skenario adalah alat menguji strategi, bukan ramalan (van der Heijden, 2005). Bila kelak dibutuhkan estimasi peluang, metode Delphi dengan panel ahli dapat ditambahkan sebagai tahap terpisah.</p><h3>7.6 Peta jalan transformasi</h3><p>Peta jalan transformasi 2026–2032 · 3 fase, inisiatif dan KPI. Setiap fase dirancang membiayai fase berikutnya (<em>self-funding</em>) dari penghematan biaya transportasi.</p><h3>7.7 Dampak finansial</h3><p>Kasus bisnis disusun untuk distributor representatif, bukan dari data perusahaan tertentu. Asumsi ilustratifnya: penjualan Rp10 triliun per tahun dan biaya transportasi 0,75% dari penjualan, atau sekitar Rp75 miliar per tahun. Target penghematan dinyatakan sebagai penurunan rasio tersebut, sehingga dapat diskalakan ke distributor berukuran berbeda: setiap Rp1 triliun penjualan menghasilkan sepersepuluh dari angka pada tabel berikut.</p><p><strong>Fase</strong></p><p><strong>Penurunan rasio</strong></p><p><strong>Rasio biaya transportasi</strong></p><p><strong>Penghematan per tahun</strong></p><p>Baseline (2025)</p><p>–</p><p>0,75%</p><p>–</p><p>Fase 2 (akhir 2028)</p><p>8–10%</p><p>0,68–0,69%</p><p>Rp6,0–7,5 miliar</p><p>Fase 3 (2032)</p><p>12–15%</p><p>0,64–0,66%</p><p>Rp9,0–11,3 miliar</p><p>Estimasi ini konservatif karena memakai biaya transportasi tahun dasar tanpa pertumbuhan volume; jika volume dan penjualan tumbuh, penghematan absolut ikut naik secara proporsional.</p><p>Di luar penghematan transportasi, inisiatif otomasi dan IoT berpotensi memberi efisiensi tenaga kerja gudang hingga sekitar 20%, penurunan kehilangan inventori 10–15% berkat pemantauan IoT, serta keunggulan posisi ESG untuk kontrak prinsipal global.</p><h3>8. Kesimpulan, Keterbatasan dan Saran</h3><h3>8.1 Kesimpulan</h3><p>1. Dua <em>driver</em> kritis, yaitu penegakan regulasi &amp; ESG serta adopsi digital &amp; AI, membentuk empat skenario masa depan distribusi farmasi Indonesia hingga 2032.</p><p>2. AHP menempatkan S2 — Smart Regulated Network sebagai profil kesiapan paling kokoh (0,391), diikuti S1 (0,359), S3 (0,163) dan S4 (0,087), dengan seluruh CR di bawah 0,10.</p><p>3. S2 menang bukan karena unggul di kriteria terberat, melainkan karena unggul di banyak kriteria berbobot menengah sambil tetap memenuhi kepatuhan pada tingkat kompetitif.</p><p>4. Pesan strategisnya: Healthcare Distributor tidak boleh memaksimalkan kepatuhan semata, tetapi harus menyeimbangkannya dengan transformasi digital dan jaringan. Tanpa itu, perusahaan berisiko terseret ke S1 (erosi margin) atau tersisih di S4 (disintermediasi).</p><p>5. Empat <em>no-regret moves</em> (kepatuhan digital &amp; ketertelusuran, AI <em>routing</em>, optimasi jaringan, <em>control tower</em>) layak dijalankan segera karena bernilai di semua skenario.</p><h3>8.2 Keterbatasan</h3><p>• <strong>Dominasi satu kriteria.</strong> Rekomendasi S2 bergantung pada pandangan panel tentang seberapa dominan kepatuhan; peringkat berbalik bila bobot Compliance melewati sekitar 54,2% (Bagian 6.4).</p><p>• <strong>Diferensiasi terbatas.</strong> Selisih S2 dan S1 hanya 0,032, sehingga daya pembeda model relatif rendah.</p><p>• <strong>Bobot Cost sangat kecil (5,4%).</strong> Padahal biaya logistik nasional masih 14,29% PDB dan menjadi tekanan nyata; model mungkin kurang mencerminkan dinamika persaingan harga.</p><p>• <strong>Alternatif berupa skenario.</strong> Skenario adalah kondisi eksternal, sehingga hasil AHP harus dibaca sebagai keselarasan postur, bukan pilihan masa depan (lihat 3.6).</p><p>• <strong>Pola matriks berulang.</strong> Matriks Compliance, Digital dan Service memakai pola nilai yang sama (1, 3, 5, 7) dengan urutan berbeda, sehingga prioritas lokalnya identik. Pola ini wajar untuk konsensus kasar, tetapi menandakan penilaian belum sangat granular.</p><p>• <strong>Basis data finansial.</strong> Kasus bisnis memakai asumsi ilustratif distributor representatif (penjualan Rp10 triliun, biaya transportasi 0,75% dari penjualan), bukan data perusahaan tertentu. Struktur biaya transportasi antar-distributor dapat berbeda jauh menurut cakupan geografis, porsi rantai dingin dan bauran pelanggan.</p><h3>8.3 Saran</h3><p>1. <strong>Uji sensitivitas lengkap.</strong> Lakukan analisis per kriteria dan simulasi Monte Carlo atas rentang penilaian ahli untuk memetakan seberapa sering S2 tetap unggul.</p><p>2. <strong>Perluas panel dan dokumentasikan.</strong> Catat jumlah responden per fungsi, CR individu sebelum agregasi, dan sertakan perwakilan prinsipal atau pelanggan rumah sakit.</p><p>3. <strong>Tambahkan indikator peringatan dini (<em>signposts</em>).</strong> Contoh: jumlah temuan audit CDOB per tahun, kepastian pajak karbon untuk transportasi, pangsa kanal farmasi online, serta masuknya pemain logistik berbasis AI. Indikator ini memberi tanda bila arah bergeser ke S1 atau S4.</p><p>4. <strong>Validasi rasio biaya transportasi.</strong> Kalibrasi asumsi rasio biaya transportasi 0,75% dengan data aktual distributor yang menerapkan kerangka ini, atau dengan tolok ukur industri yang dipublikasikan, agar kasus bisnis dapat dipertanggungjawabkan.</p><p>5. <strong>Pertimbangkan Fuzzy AHP atau ANP.</strong> Fuzzy AHP menangkap ketidakpastian penilaian ahli, sedangkan ANP menangkap ketergantungan antar-kriteria (misalnya Digital memengaruhi Cost dan Service).</p><h3>Daftar Pustaka</h3><h3>Literatur akademik</h3><p>• Barney, J. (1991). Firm resources and sustained competitive advantage. Journal of Management, 17(1), 99–120.</p><p>• Christopher, M. (2016). Logistics and Supply Chain Management (5th ed.). Pearson.</p><p>• Courtney, H., Kirkland, J., &amp; Viguerie, P. (1997). Strategy under uncertainty. Harvard Business Review, 75(6), 67–79.</p><p>• Forman, E., &amp; Peniwati, K. (1998). Aggregating individual judgments and priorities with the Analytic Hierarchy Process. European Journal of Operational Research, 108(1), 165–169.</p><p>• Ramirez, R., &amp; Wilkinson, A. (2016). Strategic Reframing: The Oxford Scenario Planning Approach. Oxford University Press.</p><p>• Rohrbeck, R., &amp; Kum, M. E. (2018). Corporate foresight and its impact on firm performance: A longitudinal analysis. Technological Forecasting and Social Change, 129, 105–116.</p><p>• Saaty, T. L. (1980). The Analytic Hierarchy Process. McGraw-Hill.</p><p>• Saaty, T. L. (1990). How to make a decision: The Analytic Hierarchy Process. European Journal of Operational Research, 48(1), 9–26.</p><p>• Schoemaker, P. J. H. (1995). Scenario planning: A tool for strategic thinking. Sloan Management Review, 36(2), 25–40.</p><p>• Schwartz, P. (1991). The Art of the Long View. Doubleday.</p><p>• Stewart, T. J., French, S., &amp; Rios, J. (2013). Integrating multicriteria decision analysis and scenario planning. Omega, 41(4), 679–688.</p><p>• Teece, D. J., Pisano, G., &amp; Shuen, A. (1997). Dynamic capabilities and strategic management. Strategic Management Journal, 18(7), 509–533.</p><p>• Vaidya, O. S., &amp; Kumar, S. (2006). Analytic hierarchy process: An overview of applications. European Journal of Operational Research, 169(1), 1–29.</p><p>• van der Heijden, K. (2005). Scenarios: The Art of Strategic Conversation (2nd ed.). Wiley.</p><p>• Wack, P. (1985). Scenarios: Uncharted waters ahead. Harvard Business Review, 63(5), 73–89.</p><h3>Regulasi dan data industri</h3><p>• <a href="https://chaindrugreview.com/pharmaceutical-distributors-report-growth-despite-tight-margins">Chain Drug Review (2025). Pharmaceutical distributors report growth despite tight margins (data HDA Factbook, edisi ke-96, HDA Research Foundation).</a></p><p>• <a href="https://bpjph.halal.go.id/read/bpjph-dorong-industri-farmasi-bersiap-sambut-wajib-halal-oktober-2026">BPJPH (2025). BPJPH dorong industri farmasi bersiap sambut wajib halal Oktober 2026 (PP №42 Tahun 2024).</a></p><p>• <a href="https://news.sah.co.id/standar-cara-distribusi-obat-yang-baik-cdob/?amp=1">SAH (2025). Standar Cara Distribusi Obat yang Baik (Peraturan BPOM №20 Tahun 2025).</a></p><p>• <a href="https://rri.co.id/en/national/2379761/indonesia-pushes-multimodal-logistics-to-cut-costs-at-1429-percent-gdp">RRI (2026). Indonesia pushes multimodal logistics to cut costs at 14.29 percent GDP.</a></p><p>• <a href="https://pwc.com/id/en/media-centre/infrastructure-news/august-2023/logistics-performance-lessons-learned-for-indonesia.html">PwC Indonesia (2023). Logistics performance: Lessons learned for Indonesia.</a></p><p>• <a href="https://pajakku.com/artikel/ketentuan-pajak-karbon-indonesia-contoh-hitungnya">Pajakku (2024, diperbarui 2026). Ketentuan pajak karbon Indonesia.</a></p><p>• <a href="https://ekonomi.bisnis.com/read/20240629/257/1778018/opini-menguak-potensi-industri-farmasi-indonesia">Bisnis.com (2024). Menguak potensi industri farmasi Indonesia (data IQVIA 2023).</a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=54e3362f9019" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>